Tagantibodies

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence

T

van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus...

Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia

O

Shih, Sophy & Cheng, Qinglu & Carson, Joanne & Valerio, Heather & Sheehan, Yumi & Gray, Richard & Cunningham, Evan & Kwon, Jisoo & Lloyd, Andrew & Dore, Gregory & Wiseman, Virginia & Grebely, Jason. (2023). Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost...

Watch on-demand: Sessions from the 1st Australasian Conference on Point of Care Testing

W

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), 26/04/2023 The inaugural 1st Australasian Conference on Point of Care Testing for Infectious Diseases was an outstanding achievement. Hosted at the Sheraton Grand Sydney Hyde Park on the 14th and 15th of March, the conference attracted over 270 attendees from 19 different countries, representing numerous disciplines...

Monkeypox update: Your Questions Answered video with Dr Dr Vincent Cornelisse / Updated Clinical Guidance from ATAGI / Responding to MPX: GBM in Australia (Survey)

M

MPX – Monkeypox – Your Questions Answered (video) Thorne Harbour Health, 26 Aug, 2022 Thorne Harbour Health’s Cal Hawk is joined by Dr Vincent Cornelisse to unpack the latest information we have about the current global outbreak of the monkeypox virus (MPXV) including what our communities can do now to reduce their risk. Vincent is a specialist in sexual health medicine and...

What health strategies could help achieve hepatitis C elimination?

W

Kirby Institute, UNSW, Wednesday, 6 April 2022 The World Health Organization has set an ambitious target to eliminate hepatitis C as a public health threat by 2030. Some countries, including Australia, have made good progress, but if elimination is to be achieved, existing health strategies need to be scaled up and targeted toward the people most at risk, according to new research from the Kirby...

Updated Guidelines: Australian STI & HIV Testing Guidelines 2019 for Asymptomatic MSM

U

Sexually Transmissible Infections in Gay Men Action Group (STIGMA), September 2019 Most sexually transmitted infections (STIs) are asymptomatic. Testing and treatment of asymptomatic men who have sex with men (MSM) is the most effective method to interrupt transmission and reduce the burden of illness. In particular, syphilis is increasingly common, is often asymptomatic, and can cause...

Your sidebar area is currently empty. Hurry up and add some widgets.